MedPath

Evaluation Conducted to Capture Patients With Diabetic Retinopathy in General Practitioners, Using SW as Medical Device

Not Applicable
Recruiting
Conditions
Diabetes Mellitus
Interventions
Device: SW as medical devices(comperator) to evaluate the retinal image of the patient's eye (to identify if the patient has DR or if the patient is healthy) .
Registration Number
NCT06467903
Lead Sponsor
Bonmedix Holding a.s.
Brief Summary

A prospective, comparative multicenter evaluation conducted to capture patients with diabetic retinopathy in general practitioners, using AI medical device

Detailed Description

A prospective, comparative multicenter evaluation conducted to capture patients with diabetic retinopathy in general practitioners, using the SWaMD medical device and the SWaMD comparator, when evaluating the patients retinal image

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Men and women aged ≥ 40 years
  • Signed informed consent
  • Confirmed type 1 or 2 diabetes mellitus
Exclusion Criteria
  • Ocular findings that do not allow retinal photography (significant nystagmus, corneal leukoma, dense cataract, hemophthalmus, etc.)
  • Patient has a condition or is in a situation that, in the opinion of the investigator, may bias the results of the study, may significantly interfere with the patient's participation in the investigation, or may result in unproducible photographs of a dilated ocular fundus
  • Patients with restrictions on personal freedom by administrative or legal order

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
one arm - 1000 patients, DR screeningSW as medical devices(comperator) to evaluate the retinal image of the patient's eye (to identify if the patient has DR or if the patient is healthy) .SW as medical devices(investigational device) to evaluate the retinal image of the patient's eye (to identify if the patient has DR or if the patient is healthy) .
Primary Outcome Measures
NameTimeMethod
Sensitivity and specificity3 months

The sensitivity and specificity will be calculated using the evaluation of independent masked expert (ophthalmologist) as gold standard.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Jakub Sedivy

🇨🇿

Příbram, Or, Czechia

© Copyright 2025. All Rights Reserved by MedPath